GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neurobiological Technologies Inc (OTCPK:NTII) » Definitions » Shiller PE Ratio

Neurobiological Technologies (Neurobiological Technologies) Shiller PE Ratio : (As of Jun. 06, 2024)


View and export this data going back to 1994. Start your Free Trial

What is Neurobiological Technologies Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Neurobiological Technologies Shiller PE Ratio Historical Data

The historical data trend for Neurobiological Technologies's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurobiological Technologies Shiller PE Ratio Chart

Neurobiological Technologies Annual Data
Trend Jun00 Jun01 Jun02 Jun03 Jun04 Jun05 Jun06 Jun07 Jun08 Jun09
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - -0.48 -0.23

Neurobiological Technologies Quarterly Data
Dec04 Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.19 -0.10 -0.22 -0.23 -0.32

Competitive Comparison of Neurobiological Technologies's Shiller PE Ratio

For the Biotechnology subindustry, Neurobiological Technologies's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neurobiological Technologies's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Neurobiological Technologies's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Neurobiological Technologies's Shiller PE Ratio falls into.



Neurobiological Technologies Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Neurobiological Technologies's E10 for the quarter that ended in Sep. 2009 is calculated as:

For example, Neurobiological Technologies's adjusted earnings per share data for the three months ended in Sep. 2009 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Sep. 2009 (Change)*Current CPI (Sep. 2009)
=0.2/91.1196*91.1196
=0.200

Current CPI (Sep. 2009) = 91.1196.

Neurobiological Technologies Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
199912 -0.490 71.008 -0.629
200003 -0.350 72.231 -0.442
200006 -0.420 72.737 -0.526
200009 -0.280 73.286 -0.348
200012 0.560 73.413 0.695
200103 -0.490 74.341 -0.601
200106 0.560 75.100 0.679
200109 -0.280 75.227 -0.339
200112 -0.350 74.552 -0.428
200203 -0.420 75.438 -0.507
200206 -0.700 75.902 -0.840
200209 0.000 76.366 0.000
200212 -0.490 76.324 -0.585
200303 -0.280 77.716 -0.328
200306 -0.280 77.505 -0.329
200309 -0.350 78.138 -0.408
200312 -0.420 77.758 -0.492
200403 0.350 79.066 0.403
200406 -0.350 80.037 -0.398
200409 -1.610 80.121 -1.831
200412 -0.700 80.290 -0.794
200503 -0.910 81.555 -1.017
200506 -3.430 82.062 -3.809
200509 -1.050 83.876 -1.141
200512 -3.850 83.032 -4.225
200603 -0.840 84.298 -0.908
200606 -1.148 85.606 -1.222
200609 -0.570 85.606 -0.607
200612 -0.770 85.142 -0.824
200703 -1.040 86.640 -1.094
200706 -0.910 87.906 -0.943
200709 -0.190 87.964 -0.197
200712 -0.360 88.616 -0.370
200803 -0.190 90.090 -0.192
200806 -0.080 92.320 -0.079
200809 -0.100 92.307 -0.099
200812 -0.290 88.697 -0.298
200903 -0.020 89.744 -0.020
200906 0.530 91.003 0.531
200909 0.200 91.120 0.200

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Neurobiological Technologies  (OTCPK:NTII) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Neurobiological Technologies Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Neurobiological Technologies's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Neurobiological Technologies (Neurobiological Technologies) Business Description

Traded in Other Exchanges
N/A
Address
2010 Crow Canyon Place, Suite 100, San Ramon, CA, USA, 94583
Neurobiological Technologies Inc is a biopharmaceutical company historically focused on developing investigational drugs for central nervous system conditions.
Executives
Ariel Warszawski 10 percent owner C/O FIREFLY VALUE PARTNERS, LP, 551 FIFTH AVENUE, 36TH FLOOR, NEW YORK NY 10176
Ryan Heslop 10 percent owner C/O FIREFLY VALUE PARTNERS, LP, 551 FIFTH AVENUE, 36TH FLOOR, NEW YORK NY 10176
Firefly Management Co Gp, Llc 10 percent owner C/O FIREFLY VALUE PARTNERS, LP, 551 FIFTH AVENUE, 36TH FLOOR, NEW YORK NY 10176
Fvp Gp, Llc 10 percent owner C/O FIREFLY VALUE PARTNERS, LP, 551 FIFTH AVENUE, 36TH FLOOR, NEW YORK NY 10176
Firefly Value Partners, Lp 10 percent owner 426 PINEVILLE ROAD, UNIT 1, NEWTOWN PA 18940
Fvp Master Fund Lp 10 percent owner FVP GP LLC, 551 FIFTH AVENUE, 36TH FLOOR, New York NY 10176
John B Stuppin director
Abraham E Cohen director 500 SEVENTH AVE 10TH FL, C/O AXONYX INC, NEW YORK NY 10018
Abraham D Sofaer director HOOVER INSTITUTION, STANFORD UNIVERSITY, STANFORD CA 94305-6010
Biotechnology Value Fund L P other: Direct Beneficial Owner 44 MONTGOMERY STREET, 40TH FL, SAN FRANCISCO CA 94104
Bvf Partners L P/il 10 percent owner 44 MONTGOMERY ST., 40TH FLOOR, SAN FRANCISCO CA 94104
Bvf Inc/il 10 percent owner 44 MONTGOMERY STREET, 40TH FL, SAN FRANCISCO CA 94104
Biotechnology Value Fund Ii Lp other: Direct Beneficial Owner 44 MONTGOMERY STREET, 40TH FL, SAN FRANCISCO CA 94104
Bvf Investments Llc other: Direct Beneficial Owner 1 SANSOME ST, 30TH FL, SAN FRANCISCO CA 94104
Mark N Lampert 10 percent owner 1 SANSOME ST, 30TH FL, SAN FRANCISCO CA 94104

Neurobiological Technologies (Neurobiological Technologies) Headlines